Drugs / MPA
last change Sep 2008 re-read 2 minutes ago

MPA

Developed for
endometrial disorder · osteoporosis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00242710 Comparator Sep 2005 → Sep 2008 endometrial disorder, osteoporosis Pfizer Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MPA ClinicalTrials.gov intervention name — accepted as the source's own label NCT00242710